Literature DB >> 9397016

Miyoshi-type distal muscular dystrophy. Clinical spectrum in 24 Dutch patients.

W H Linssen1, N C Notermans, Y Van der Graaf, J H Wokke, P A Van Doorn, C J Höweler, H F Busch, A E De Jager, M De Visser.   

Abstract

Miyoshi-type distal muscular dystrophy has now been found to be more frequent outside Japan than was previously thought. We studied 24 Dutch patients with Miyoshi-type distal muscular dystrophy and focused on its clinical expression and natural history, muscle CT-scans and muscle biopsy findings. Our study shows that Miyoshi myopathy is a heterogeneous, slowly progressive disorder. The disease starts with weakness and atrophy of the calves and progressively involves the proximal leg and hip muscles and, in a later stage the shoulder and upper arm muscles. After 10 years disease duration, one-third of the patients are dependent on wheelchairs for out-of-door transportation. Disease progression is related to disease duration and not to early age of onset of symptoms. Onset may be at any age and is asymmetrical in roughly half of the cases. Four cases had been initially diagnosed as idiopathic hyper-CK-aemia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9397016     DOI: 10.1093/brain/120.11.1989

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  15 in total

1.  Atypical Miyoshi distal myopathy: A case report.

Authors:  Meiling Wang; Yujie Guo; Yong Fu; Rui Jia; Gang Chen
Journal:  Exp Ther Med       Date:  2016-09-20       Impact factor: 2.447

2.  A new distal myopathy with mutation in anoctamin 5.

Authors:  Ibrahim Mahjneh; Jyoti Jaiswal; Antti Lamminen; Mirja Somer; Gareth Marlow; Sari Kiuru-Enari; Rumaisa Bashir
Journal:  Neuromuscul Disord       Date:  2010-08-07       Impact factor: 4.296

3.  Limited proteolysis as a tool to probe the tertiary conformation of dysferlin and structural consequences of patient missense variant L344P.

Authors:  Natalie Woolger; Adam Bournazos; Reece A Sophocleous; Frances J Evesson; Angela Lek; Birgit Driemer; R Bryan Sutton; Sandra T Cooper
Journal:  J Biol Chem       Date:  2017-09-13       Impact factor: 5.157

4.  Clinical and pathological characteristics of four Korean patients with limb-girdle muscular dystrophy type 2B.

Authors:  Seung-Hun Oh; Seong-Woong Kang; Jin-Goo Lee; Sang-Jun Na; Tai-Seung Kim; Young-Chul Choi
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

Review 5.  Distal myopathies.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Neurol Clin       Date:  2014-05-15       Impact factor: 3.806

6.  Myogenesis in dysferlin-deficient myoblasts is inhibited by an intrinsic inflammatory response.

Authors:  Tatiana V Cohen; Jonathan E Cohen; Terence A Partridge
Journal:  Neuromuscul Disord       Date:  2012-05-03       Impact factor: 4.296

7.  Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs.

Authors:  Dirk Fischer; Maggie C Walter; Kristina Kesper; Jens A Petersen; Stefania Aurino; Vincenzo Nigro; Christian Kubisch; Thomas Meindl; Hanns Lochmüller; Kai Wilhelm; Horst Urbach; Rolf Schröder
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

8.  Clinical, Neurophysiological, Radiological, Pathological, and Genetic Features of Dysferlinopathy in Saudi Arabia.

Authors:  Norah Alharbi; Rawan Matar; Edward Cupler; Hindi Al-Hindi; Hatem Murad; Iftteah Alhomud; Dorota Monies; Ali Alshehri; Mossaed Alyahya; Brian Meyer; Saeed Bohlega
Journal:  Front Neurosci       Date:  2022-02-22       Impact factor: 4.677

9.  New aspects on patients affected by dysferlin deficient muscular dystrophy.

Authors:  Lars Klinge; Ahmed Aboumousa; Michelle Eagle; Judith Hudson; Anna Sarkozy; Gianluca Vita; Richard Charlton; Mark Roberts; Volker Straub; Rita Barresi; Hanns Lochmüller; Kate Bushby
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-06-14       Impact factor: 10.154

10.  Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial.

Authors:  Maggie C Walter; Peter Reilich; Simone Thiele; Joachim Schessl; Herbert Schreiber; Karlheinz Reiners; Wolfram Kress; Clemens Müller-Reible; Matthias Vorgerd; Peter Urban; Bertold Schrank; Marcus Deschauer; Beate Schlotter-Weigel; Ralf Kohnen; Hanns Lochmüller
Journal:  Orphanet J Rare Dis       Date:  2013-02-14       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.